NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

Urgent screening resources to combat CPE superbugs awaited

By Catherine Reilly - 04th Mar 2019

Further screening resources required immediately to help combat carbapenemase-producing Enterobacteriaceae (CPE) have not yet been provided by the Department of Health for 2019, the Medical Independent (MI) understands.

At press time, the HSE and Department were due to discuss some additional funding. To date, MI understands the Department had committed to around €2 million for 2019, which represents the full-year costs of new posts agreed in 2018.

In June 2018, the HSE warned the Department that the National Lead for healthcare-associated infection (HCAI) and antimicrobial resistance (AMR) Prof Martin Cormican advised of an “urgent need to progress full implementation of guidance on CPE screening if we are to respond effectively to the CPE public health emergency”.

As part of the 2019 estimates process, the HSE sought resources to carry out the required level of screening, with €3.1 million requested for an additional 15 laboratory posts (€0.595 million) and laboratory supplies for testing (€2.5 million).

However, the requested funding for screening has not yet been provided. In June, the then HSE interim Director General Mr John Connaghan informed Chief Medical Officer Dr Tony Holohan that “the €2 million allocation is clearly not sufficient to cover the full costs of immediate implementation of the CPE Screening Guidelines”.

He wrote that Prof Cormican’s advised that “delay in implementing screening guidance materially increases the risk that CPE will become irreversibly endemic in our healthcare system”.

It is understood the HSE considers resources for screening, managing patients with CPE, infection prevention and control staff deficits, and healthcare infrastructure as the key elements of combatting CPE.

In January, The Irish Times reported that the Government had approved €20 million for a three-year plan to tackle CPE and quoted Minister for Health Simon Harris.

However, when contacted by MI, the Department did not confirm this funding. A spokesperson said it allocated dedicated funding in 2018 and work was underway to “prioritise work programmes and allocate funding for 2019”.

Speaking to MI on 23 February, Prof Cormican said some “very good progress” was made in 2018. However, he said “we will need to up the game quite a bit in 2019 and 2020 if we are actually going to try and put this back in the box”.

CPE was declared a public health emergency by Minister Harris in October 2017.

Leave a Reply

Latest Issue
medical independent 21st November
The Medical Independent 21st November 2023

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read